Acetaminophen (paracetamol) is a selective cyclooxygenase‐2 inhibitor in man
The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
For more than three decades, acetaminophen (INN, paracetamol) has been claimed to be devoid of significant inhibition of peripheral prostanoids. Meanwhile, attempts to explain its action by inhibition of a central cyclooxygenase (COX)‐3 have been rejected. The fact that acetaminophen acts functionally as a selective COX‐2 inhibitor led us to investigate the hypothesis of whether it works via preferential COX‐2 blockade. Ex vivo COX inhibition and pharma‐cokinetics of acetaminophen were assessed in 5 volunteers receiving single 1000 mg doses orally. Coagulation‐induced thromboxane B 2 and lipopolysaccharide‐induced prostaglandin E 2 were measured ex vivo and in vitro in human whole blood as indices of COX‐1 and COX‐2 activity. In vitro , acetaminophen elicited a 4.4‐fold selectivity toward COX‐2 inhibition (IC 50 = 113.7 μmol/L for COX‐1;IC 50 = 25.8 μmol/L for COX‐2). Following oral administration of the drug, maximal ex vivo inhibitions were 56% (COX‐1) and 83% (COX‐2). Acetaminophen plasma concentrations remained above the in vitro IC 50 for COX‐2 for at least 5 h postadministration. Ex vivo IC 50 values (COX‐1: 105.2 μmol/L; COX‐2: 26.3 μmol/L) of acetaminophen compared favorably with its in vitro IC 50 values. In contrast to previous concepts, acetaminophen inhibited COX‐2 by more than 80%, i.e. , to a degree comparable to nonste‐roidal antiinflammatory drugs (NSAIDs) and selective COX‐2 inhibitors. However, a >95% COX‐1 blockade relevant for suppression of platelet function was not achieved. Our data may explain acetaminophen's analgesic and antiinflammatory action as well as its superior overall gastrointestinal safety profile compared with NSAIDs. In view of its substantial COX‐2 inhibition, recently defined cardiovascular warnings for use of COX‐2 inhibitors should also be considered for acetaminophen.—Hinz, B., Cheremina, O., Brune, K. Acetaminophen (paracetamol) is a selective cyclooxygenase‐2 inhibitor in man. FASEB J. 22, 383–390 (2007)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hinz et al. (2007) demonstrated 4.4x more selectivity toward the inhibition of COX-2 (IC 50 = 25.8 µmol/L) over COX-1 (IC 50 = 113.7 µmol/ L) from in vitro assays using whole human blood [51].”
From Paracetamol (acetaminophen): A familiar drug with an unexplained mechanism of action (2021) · cites this paper as [51]
In the citing paper
“In this study, paracetamol demonstrated over 80% blockade of COX-2 activity comparable to NSAIDs and COX-2 selective inhibitors.”
From Paracetamol (acetaminophen): A familiar drug with an unexplained mechanism of action (2021) · cites this paper as [51]
In the citing paper
“It is not clear why there are significant discrepancies in relation to inhibition of COX-1 and COX-2 activities by paracetamol as reported by Hinz et al. [51] and Mitchell et al. [33].”
From Paracetamol (acetaminophen): A familiar drug with an unexplained mechanism of action (2021) · cites this paper as [51]
Citations
Cites
Chandrasekharan, N. V., Dai, H., Roos, K. L. T., Evanson, N. K., Tomsik, J., Elton, T. S., & Simmons, D. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162468699 · Cited by 1,989 · cited 2×
“Attempts to explain the pharmacological action of acetaminophen as inhibition of a central COX isoform, derived from the same gene as COX-1 and referred to as COX-3 (8), have been meanwhile rejected for several reasons (9).”
BackgroundCyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin
Catella-Lawson, F., Reilly, M. P., Kapoor, S. C., Cucchiara, A. J., DeMarco, S., Tournier, B., Vyas, S. N., & FitzGerald, G. A. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa003199 · Cited by 1,394
The antioxidants of human extracellular fluids
Halliwell, B., & Gutteridge, J. M. C. (1990) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(90)90510-6 · Cited by 1,341 · cited 1×
“Thus, the presence of various enzymatic and nonenzymatic antioxidant components in human plasma (33) may explain why acetaminophen elicited the most pronounced COX-2 inhibition in human whole blood as compared to the two other experimental systems.”
ResultSerhan, C. N., Clish, C. B., Brannon, J., Colgan, S. P., Chiang, N., & Gronert, K. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.8.1197 · Cited by 1,189 · cited 1×
“Apart from these factors, evidence for COX-2 inhibition by acetaminophen is also supported by previous findings showing that acetaminophen like indomethacin and aspirin confers the synthesis of 18R-hydroxyeicosapentaenoic acid (HEPE) and 15RHEPE through interaction with the COX-2 enzyme (34).”
ResultLangenbach, R., Morham, S. G., Tiano, H. F., Loftin, C. D., Ghanayem, B. I., Chulada, P. C., Mahler, J. F., Lee, C. A., Goulding, E. H., Kluckman, K. D., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90126-4 · Cited by 1,123 · cited 1×
“A COXindependent mechanism for the gastrointestinal toxicity of NSAIDs is further supported by findings in COX-1 knockout mice, which still develop gastric erosions in response to oral administration of indomethacin (45).”
BackgroundPharmacological analysis of cyclooxygenase-1 in inflammation
Smith, C. J., Zhang, Y., Koboldt, C. M., Muhammad, J., Zweifel, B. S., Shaffer, A., Talley, J. J., Masferrer, J. L., Seibert, K., & Isakson, P. C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13313 · Cited by 807 · cited 2×
“A peripheral antiinflammatory action is further supported by findings showing acetaminophen as an inhibitor of nociception and edema in the rat carrageenan footpad model (27, 28), an inflammatory condition critically dependent on COX-2-derived PGs (29).”
BackgroundFLOWER, R. J., & VANE, J. R. (1972) · Nature · doi:10.1038/240410a0 · Cited by 779 · cited 2×
“Whereas the drug was first associated with a predominant suppression of PG synthesis in brain tissue ( 3 ), subsequent studies contradicted a cell-specific modulation (4 –7).”
BackgroundMethodMechanism of Action of Paracetamol
Graham, G. G., & Scott, K. F. (2005) · American Journal of Therapeutics · doi:10.1097/00045391-200501000-00008 · Cited by 648 · cited 4×
“Moreover, it turned out that acetaminophen elicits no measurable inhibition of PG formation in broken cell preparations but a profound suppression in intact cells (7).”
BackgroundInfluentialNonsteroidal anti-inflammatory drugs and gastroenteropathy: The second hundred years
Wallace, J. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9041264 · Cited by 569
Cannon, C. P., Curtis, S. P., FitzGerald, G. A., Krum, H., Kaur, A., Bolognese, J. A., Reicin, A. S., Bombardier, C., Weinblatt, M. E., van der Heijde, D., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69666-9 · Cited by 522 · cited 1×
“PGE2 is the currently most plausible explanation for the cardiovascular hazard conferred by selective and nonselective COX-2 inhibitors (20, 30).”
Background
Research works printed but not linked: 1
- Mantzke U. S., 2002, Paracetamol in childhood. Current state of knowledge and indications for a rational approach to postoperative analgesia, Anaesthesist, 51, 735
Cited by
Items 201–300 of 489
Pan, J., Ji, N., Pan, W., Ru, H., Wang, H., & Ji, Z. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.10.017 · Cited by 17
“Recent research proposed that the prostaglandin G/H synthase 2 (COX2) may be the therapeutic target of acetaminophen (Hinz et al., 2008).”
BackgroundImidazolium Chloride: An Efficient Catalyst for Transamidation of Primary Amines
Tian, Q., Gan, Z., Wang, X., Li, D., Luo, W., Wang, H., Dai, Z., & Yuan, J. (2018) · Molecules · doi:10.3390/molecules23092234 · Cited by 17
“In addition, amide is also an important structural core of many FDA approved drugs, such as formoterol [5], itopride [6], trametinib [7], apremilast [8], paracetamol [9], and procainamide [10] (Figure 1).”
BackgroundPerioperative Schmerztherapie bei abdominellen und thorakalen Operationen
Englbrecht, J. S., & Pogatzki-Zahn, E. M. (2014) · Der Schmerz · doi:10.1007/s00482-014-1420-8 · Cited by 17
Cinquina, V., Keimpema, E., Pollak, D. D., & Harkany, T. (2023) · Journal of Neuroendocrinology · doi:10.1111/jne.13320 · Cited by 18
“Kim et al. 138 Abbreviations: AA, arachidonic acid; DHA, docosahexaenoic acid; DHEA, dehydroepiandrosterone; EPA, eicosapentaenoic acid; PUFAs, polyunsaturated fatty acids. is a target for acetaminophen (paracetamol), 156 as well as non-steroidal anti-inflammatory drugs 157 (Figure 3).”
BackgroundNeurologic Regulation and Orthodontic Tooth Movement
Kyrkanides, S., Huang, H., & Faber, R. D. (2015) · Frontiers of oral physiology/Frontiers of oral biology · doi:10.1159/000351900 · Cited by 18
Köhler‐Forsberg, O., Petersen, L. V., Benros, M. E., Mors, O. N., & Gasse, C. (2016) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2016.1168400 · Cited by 16
“and might also act via COX-2 inhibition,[14] but it has not been”
BackgroundLorenzini, K. I., Besson, M. J., Daali, Y., Salomon, D., Dayer, P., & Desmeules, J. A. (2011) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2011.00733.x · Cited by 18
Quantification of active ingredients in suppositories by FT‐Raman spectroscopy
Szostak, R., & Mazurek, S. (2012) · Drug Testing and Analysis · doi:10.1002/dta.379 · Cited by 16
Raza, H., & John, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0145965 · Cited by 16
Prakash, R., Sandhya, E., Ramya, N., Dhivya, R., Priyadarshini, M., & Sakthi Priya, B. (2017) · Translational Biomedicine · doi:10.21767/2172-0479.100135 · Cited by 16
Saleem, U., Ahmad, B., Ahmad, M., Hussain, K., & Bukhari, N. I. (2015) · Asian Pacific Journal of Tropical Disease · doi:10.1016/s2222-1808(14)60791-x · Cited by 16
Moore, R. A., Derry, S., Aldington, D. J., & Wiffen, P. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011407 · Cited by 16
Konzepte zur perioperativen Schmerztherapie
Reichl, S., & Pogatzki-Zahn, E. M. (2009) · Der Anaesthesist · doi:10.1007/s00101-009-1589-x · Cited by 15
Jeon, Y., Baek, S.-U., Park, S.-S., Kim, S., Baek, W.-Y., & Yeo, J. (2010) · Korean Journal of Anesthesiology · doi:10.4097/kjae.2010.59.1.13 · Cited by 15
“From animal studies, its anti-nociceptive effects reflect a combination of peripheral and central actions resulting from COX-2 inhibition [8,9].”
BackgroundRose, M. A., Juergens, C., Schmöele-Thoma, B., Gruber, W. C., Baker, S. A., & Zielen, S. (2013) · BMC Pediatrics · doi:10.1186/1471-2431-13-98 · Cited by 16
“Local reactions in children generally occur more frequently after a booster dose such that the weak anti-inflammatory mechanism of paracetamol may not be sufficient to control inflammation, suggesting that ibuprofen may be a better alternative if required [11].”
BackgroundPain Management - Practices, Novel Therapies and Bioactives
Waisundara, V. Y., Banjari, I., & Balkić, J. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.87267 · Cited by 17
Daniel, D., Nunes, B., Pinto, E., Ferreira, I. M. P. L. V. O., & Correia, A. T. (2022) · Biology · doi:10.3390/biology11040581 · Cited by 15
“COX isoforms (both COX-1 and COX-2) are the main target of the pharmaceutical class of the NSAIDs in mammals [103,104] and seem also to be affected by PAR, but to a lesser extent [52,105,106].”
BackgroundBashir, S., & Morgan, W. A. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121194 · Cited by 15
Schachtel, B. P., Voelker, M., Sanner, K. M., Gagney, D., Bey, M., Schachtel, E., & Becka, M. (2010) · The Journal of Clinical Pharmacology · doi:10.1177/0091270009360978 · Cited by 15
“Though the mechanism of action of APAP resembles that of nonsteroidal anti-inflammatory drugs, it is commonly stated that APAP acts centrally and is only a weak inhibitor of COX-2,(41,42) and its actual mechanism of action as an analgesic is still undergoing investigation.(43) In this study, differentiation of ASA Fig…”
BackgroundPolypharmazie und Schmerztherapie
Gosch, M., Böhmdorfer, B., Benvenuti-Falger, U., Dovjak, P., Iglseder, B., Lechleitner, M., Otto, R., Roller, R. E., & Sommeregger, U. (2010) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-010-0788-z · Cited by 15
“dass diese Analgetika über eine Hemmung der Prostaglandinbildung im ZNS wirken, dies wurde jedoch bisher nicht bestätigt [35].”
BackgroundBarbosa, I., Pizarro, I., Freitas, R., & Nunes, B. (2020) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2020.103377 · Cited by 15
Vijayakaran, K., Kannan, K., Kesavan, M., Suresh, S., Sankar, P., Tandan, S. K., & Sarkar, S. N. (2014) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2013.12.015 · Cited by 16
“Paracetamol displayed 4-fold selectivity for COX-2 inhibition and a standard dose caused almost complete COX-2 inhibition in humans, whereas only moderate COX-1 inhibition was observed (Hinz et al., 2008).”
BackgroundBrune, K., & Hinz, B. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200242 · Cited by 15
Self-citationParacetamol (acetaminophen) for chronic non-cancer pain in children and adolescents
Cooper, T. E., Fisher, E., Anderson, B. J., Wilkinson, N. M., Williams, D. G., & Eccleston, C. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012539 · Cited by 15
Benito, J., Aguado, D., de Abreu, M. B., Fernandez, F., & de Segura, I. Á. G. (2010) · British Journal of Anaesthesia · doi:10.1093/bja/aeq241 · Cited by 18
Enhanced analgesic effects of nefopam in combination with acetaminophen in rodents
Li, Q., Zhuang, Q., Gu, Y., Dai, C., Gao, X., Wang, X., Wen, H., Li, X., & Zhang, Y. (2017) · Biomedical Reports · doi:10.3892/br.2017.1032 · Cited by 15
“Although acetaminophen is among the most popular and widely used analgesics, the mechanism of its analgesic action remain uncertain, though the most suggested mechanism involves inhibition of COX activity (39).”
Celecoxib Impairs Heart Development via Inhibiting Cyclooxygenase-2 Activity in Zebrafish Embryos
Xu, D., Bu, J., Gu, S., Xia, Y., Du, J., & Wang, Y. (2011) · Anesthesiology · doi:10.1097/aln.0b013e3182039f22 · Cited by 14
Pharmacological bases of combining nonsteroidal antiinflammatory drugs and paracetamol
Tena‐Garitaonaindia, M., Rubio, J. M., Martínez-Plata, E., Martínez‐Augustin, O., & de Medina, F. S. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118069 · Cited by 14
Miranda, H. F., Noriega, V., & Prieto, J. C. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.03.008 · Cited by 13
Cutaneous Surgery in Patients Who Are Pregnant or Breastfeeding
Li, J. N., Nijhawan, R. I., & Srivastava, D. (2019) · Dermatologic Clinics · doi:10.1016/j.det.2019.03.002 · Cited by 13
Kyei, S., Koffuor, G. A., & Boampong, J. (2012) · Journal of Medical and Biomedical Sciences · Cited by 13
Effects of NSAIDs on the osteogenic differentiation of human adipose tissue-derived stromal cells
Hadjicharalambous, C., Alexaki, V. I., Alpantaki, K., & Chatzinikolaidou, Μ. (2016) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12595 · Cited by 13
Effects of NSAIDs on pre‑osteoblast viability and osteogenic differentiation
Hadjicharalambous, C., Alpantaki, K., & Chatzinikolaidou, Μ. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10172 · Cited by 15
“Paracetamol was also investigated in this study; it is not a typical NSAID, but it appears to inhibit COX‐2 to a degree similar to that of selective COX2 inhibitors and other NSAIDs (40).”
ResultNwaehujor, C. O., Udegbunam, R. I., Ode, J. O., & Udegbunam, S. O. (2015) · Journal of the Korean Society for Applied Biological Chemistry · doi:10.1007/s13765-015-0011-4 · Cited by 13
“NSAIDS such as Diclofenac and acetylsalicylic acid inhibit cyclo-oxygenase expression in peripheral tissues thereby interfering with prostaglandin synthesis, thus are used as anti-pyretic agents (Hinz et al. 2008; Lawal et al. 2010).”
BackgroundAnalgesic use in relation to sex hormone and prolactin concentrations in premenopausal women
Bauer, S. R., Fortner, R. T., Gates, M. A., Eliassen, A. H., Hankinson, S. E., & Tworoger, S. S. (2013) · Cancer Causes & Control · doi:10.1007/s10552-013-0186-0 · Cited by 13
“The concentrations of both COX-2 and prostaglandins , particularly prostaglandin E 2 (PGE 2 ), are increased in the presence of inflammation and other stimuli as well as in tumor and metastatic tissue [43].”
InfluentialBurman, A., García-Milian, R., Wood, M., DeWitt, N. A., Vasiliou, V., Guller, S. M., Abrahams, V. M., & Whirledge, S. (2020) · Placenta · doi:10.1016/j.placenta.2020.12.002 · Cited by 13
Anti-inflammatory and immunosuppressant drugs
Rang, H. P., Dale, M. M., Ritter, J. M., Flower, R. J., & Henderson, G. (2012) · Elsevier eBooks · doi:10.1016/b978-0-7020-3471-8.00026-3 · Cited by 13
Paracetamol for acute treatment of episodic tension-type headache in adults
Stephens, G., Derry, S., & Moore, R. A. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011889 · Cited by 13
Gnana Raja, M. (2012) · Journal of Chromatography & Separation Techniques · doi:10.4172/2157-7064.1000155 · Cited by 12
Tran‐Guzman, A., & Culty, M. (2022) · Frontiers in Toxicology · doi:10.3389/ftox.2022.842565 · Cited by 15
Borisagar, S., Jayswal, U. P., Patel, H. U., & Patel, C. N. (2011) · Pharmaceutical Methods · doi:10.4103/2229-4708.84440 · Cited by 12
“It is combined with LORN in the tablet dosage form.[3-6]”
Patel, S. H., D’Lugos, A. C., Eldon, E. R., Curtis, D., Dickinson, J. M., & Carroll, C. C. (2017) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00019.2017 · Cited by 13
“Additional work in humans using IBU may provide additional insight regarding the potential role of COX in the regulation of skeletal muscle MMP and TIMP expression due to its role as a nonspecific COX inhibitor.”
BackgroundResultInfluentialPharmacology of the Equine Foot
Hopster, K., & Driessen, B. (2021) · Veterinary Clinics of North America Equine Practice · doi:10.1016/j.cveq.2021.08.004 · Cited by 13
In Vitro Inflammation Inhibition Model Based on Semi-Continuous Toll-Like Receptor Biosensing
Jeon, J.-W., Ha, U., & Paek, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105212 · Cited by 12
“Acetaminophen weakly inhibits cyclooxygenase (COX) involved in prostaglandin synthesis (refer to Figure 1) and is selective for COX-2 [46].”
BackgroundGonzalez-Valcarcel, J., Sissani, L., Labreuche, J., Bousser, M., Chamorro, Á., Fisher, M., Ford, I., Fox, K. M., Hennerici, M. G., Mattle, H. P., et al. (2016) · Stroke · doi:10.1161/strokeaha.115.012091 · Cited by 14
“NSAIDs and selective COX-2 inhibitors.(4) Considering the”
Pickering, G. P., Macian, N., Dubray, C., & Pereira, B. (2016) · Drug Design Development and Therapy · doi:10.2147/dddt.s111590 · Cited by 13
“Unlike nonsteroidal anti-inflammatory drugs, paracetamol has been demonstrated not to reduce tissue inflammation but is also suggested to act by inhibition of COX-1- and -2-mediated production of prostaglandins.(30) It may also act on a discrete COX-1 splice variant (initially thought to be a distinct isoenzyme, COX-3…”
Jones, J. P., Williamson, L. L., Konsoula, Z., Anderson, R., Reissner, K. J., & Parker, W. (2024) · Life · doi:10.3390/life14080918 · Cited by 14
“The effects of acetaminophen on neurodevelopment were never evaluated prior to its approval for use during early neurodevelopment, despite the fact that its action alters brain metabolism [13] and signaling [14,15].”
BackgroundPandolfi, S., Chirumbolo, S., Ricevuti, G., Valdenassi, L., Bjørklund, G., Lysiuk, R., Doşa, M. D., Lenchyk, L. V., & Fazio, S. (2021) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13690 · Cited by 12
Matsubara, N., Itoh, K., Mukai, H., & Nagai, S. (2011) · International Journal of Clinical Oncology · doi:10.1007/s10147-011-0312-5 · Cited by 11
“NSAIDs might inhibit the stimulation of chemical or mechanical irritation signals between pleural tissue layers resulting in inflammation and fibrin deposition, followed by pleural symphysis [24, 25].”
BackgroundAnalgesic Use and Patterns of Estrogen Metabolism in Premenopausal Women
Fortner, R. T., Oh, H., Daugherty, S. E., Xu, X., Hankinson, S. E., Ziegler, R. G., & Eliassen, A. H. (2014) · Hormones and Cancer · doi:10.1007/s12672-013-0167-5 · Cited by 11
“Inhibition of COX-1 and COX-2 results in lower prostaglandin E2 and reduced aromatase (CYP19) activity, the key enzyme in the conversion of testosterone to estradiol and androstenedione to estrone [27].”
BackgroundInfluentialAnalgetika beim geriatrischen Patienten: Unerwünschte Arzneimittelwirkungen und Interaktionen
Gosch, M. (2015) · Zeitschrift für Gerontologie und Geriatrie · doi:10.1007/s00391-015-0922-z · Cited by 11
“Es zeigte sich, dass es nach der Gabe von 1 g Paracetamol zu einer 56 %igen Hemmung von COX-1 und zu einer 83 %igen Hemmung von COX-2 kommt [29].”
Oldenhof, J., Hochberg, M. C., Schiff, M. H., & Brune, K. (2010) · Current Medical Research and Opinion · doi:10.1185/03007995.2010.481249 · Cited by 11
Self-citationAnalgesic Drugs Alter Connective Tissue Remodeling and Mechanical Properties
Carroll, C. C. (2015) · Exercise and Sport Sciences Reviews · doi:10.1249/jes.0000000000000067 · Cited by 11
“Many common NSAID are nonspecific inhibitors of COX-1 and -2, whereas recent work suggests that APAP is a potent and specific COX-2 inhibitor (13).”
BackgroundGonzález-Paz, L. A., Lossada, C. A., Fernández-Materán, F. V., Paz, J. L., Vera-Villalobos, J., & Alvarado, Y. J. (2020) · Frontiers in Physics · doi:10.3389/fphy.2020.587606 · Cited by 11
Ahmadi-Hadad, A., de Queiroz, P. C. C., Schettini, F., & Giuliano, M. (2024) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2024.104516 · Cited by 11
Paracetamol für die perioperative Analgesie: Alte Substanz – neue Erkenntnisse
Zahn, P. K., Sabatowski, R., Schug, S. A., Stamer, U. M., & Pogatzki-Zahn, E. M. (2010) · Der Anaesthesist · doi:10.1007/s00101-010-1773-z · Cited by 10
Effects of high-dose paracetamol on blood pressure in acute stroke
den Hertog, H. M., van der Worp, H. B., van Gemert, H. M. A., van Gijn, J., Koudstaal, P. J., & Dippel, D. W. J. (2011) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2011.01529.x · Cited by 10
“Paracetamol is a weak COX-1 and COX-2 inhibitor (5, 6), but at higher doses, it may exhibit stronger non-selective COX inhibitor activity and thereby affecting blood pressure (24).”
BackgroundMahajan, P., Singh, G., Kaur, R., Monga, P., Vanita, & Bhandari, S. B. (2017) · Bangladesh Journal of Medical Science · doi:10.3329/bjms.v16i3.32848 · Cited by 10
Jena, B. R., Babu, S. M., Pradhan, D. P., & Swain, S. (2017) · Pharmaceutical Regulatory Affairs Open Access · doi:10.4172/2167-7689.1000186 · Cited by 10
Afshar, E., Hashemi-Arabi, M., Salami, S., Peirouvi, T., & Pouriran, R. (2019) · Gene · doi:10.1016/j.gene.2019.02.106 · Cited by 10
Kuller, W. I., Sietsma, S., Hendriksen, S. W. M., & Šperling, D. (2021) · Porcine Health Management · doi:10.1186/s40813-021-00224-z · Cited by 10
Jahangirifard, A., Babaee, T., Alavi, S. M., Nasiri, A. A., Ghoreishi, S. M., Noori, N. M., & Mahjoubifard, M. (2014) · Anesthesiology and Pain Medicine · doi:10.5812/aapm.19862 · Cited by 10
“The recent findings suggest that it is highly selective for COX-2 (9) and is primarily metabolized in liver into non-toxic products.”
BackgroundSolmaz, F. A., & Kovalak, E. (2018) · Acta Orthopaedica et Traumatologica Turcica · doi:10.1016/j.aott.2018.02.011 · Cited by 10
Pharmakologie der Nichtopioidanalgetika
Schneider, J., Kreutz, R. H., & Bolbrinker, J. (2018) · Der Schmerz · doi:10.1007/s00482-018-0339-x · Cited by 14
Acetaminophen reduces apical root resorption during orthodontic tooth movement in rats
Kaku, M., Yamamoto, T., Yashima, Y., Izumino, J., Kagawa, H., Ikeda, K., & Tanimoto, K. (2019) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2019.04.002 · Cited by 10
Single dose oral ibuprofen plus paracetamol (acetaminophen) for acute postoperative pain
Derry, C. J., Moore, R. A., & Derry, S. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010210 · Cited by 10
Kress, H. G., & Untersteiner, G. (2016) · Current Medical Research and Opinion · doi:10.1080/03007995.2016.1254606 · Cited by 10
Zheng, Y., Peng, Q., Dong, R., Chen, T., Bao, Y., Peng, Q., & Yang, M. (2018) · Current Pharmaceutical Analysis · doi:10.2174/1573412914666180702150357 · Cited by 9
The effect of intravenous paracetamol for the prevention of rocuronium injection pain
Uzun, Ş., Erden, İ. A., Canbay, Ö., & Aypar, Ü. (2014) · The Kaohsiung Journal of Medical Sciences · doi:10.1016/j.kjms.2014.08.002 · Cited by 9
“Animal studies have revealed that the antinociceptive effects of paracetamol reflect a combination of peripheral and central actions resulting from COX-2 inhibition [14,15].”
BackgroundSchwartz, J. I., Musser, B. J., Tanaka, W. K., Taggart, W. V., Mehta, A., Gottesdiener, K. M., & Greenberg, H. E. (2015) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.194 · Cited by 9
“assessments suggest that it has the properties of a relatively weak NSAID with respect to inhibition of COX activities, although with multiple doses it may preferentially inhibit only COX-2.”
BackgroundDiagnosis and Treatment of Common Pain Syndromes and Disorders
Morgan, B. T., & Wooden, S. (2018) · Nursing Clinics of North America · doi:10.1016/j.cnur.2018.04.004 · Cited by 9
What Are Endocrine Disrupters and Where Are They Found?
Darbre, P. D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821985-0.00001-3 · Cited by 9
Prostaglandins and Bone Metabolism
Pilbeam, C. C., Choudhary, S., Blackwell, K. A., & Raisz, L. G. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373884-4.00072-0 · Cited by 17
Mügge, F. L. B., & Silva, A. M. (2015) · Endoplasmic Reticulum Stress in Diseases · doi:10.1515/ersc-2015-0001 · Cited by 9
“monocytes after 1 g acetaminophen administration to volunteers [29].”
BackgroundEnhanced detection sensitivity of Escherichia coli O157:H7 using surface-modified gold nanorods
An, S. S. A., Ramasamy, M., & Yi, D. K. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s88379 · Cited by 10
“Antispasmodic drugs with analgesics are commonly prescribed for suppressing COX-2-dependent prostaglandins synthesis.(6) O157 bacteria carry proteins, receptors, and enzymes on their surfaces, especially heme-binding enzyme catalase-peroxidases or membrane peroxidases, which are believed to be involved in the bacteria…”
BackgroundBiščević-Tokić, J., Tokić, N., & Ibrahimpasic, E. (2015) · Acta Informatica Medica · doi:10.5455/aim.2015.23.322-325 · Cited by 8
Lötsch, J., Freynhagen, R., von Hentig, N., Grießinger, N., Zimmermann, M., Sittl, R., & Geißlinger, G. (2010) · Inflammation Research · doi:10.1007/s00011-010-0215-3 · Cited by 8
“It is beginning to be recognised that absent COX function may result in quantitative changes not only in COX-2 products but also in significant off-target reductions in 5-lipoxygenase metabolites [21], suggesting a lipidomic approach which is much more comprehensive than so far thought to identify the clinical consequ…”
InfluentialParacetamol-Induced Hypothermia in Rodents: A Review on Pharmacodynamics
Coman, L., Păunescu, H., Ghiță, C. I. V., Ţincu, R. C., Vasile, S., Cinteză, D., Fulga, I., & Coman, O. A. (2022) · Processes · doi:10.3390/pr10040687 · Cited by 8
Kim, H., Bae, S., Kwon, K.-Y., Hwang, Y., Kang, J. S., & Lee, W. J. (2015) · Anatomy & Cell Biology · doi:10.5115/acb.2015.48.4.244 · Cited by 8
“Acetaminophen is an well-known COX-2 selective inhibitor [15].”
Hamed, M. A., & Al-Saeed, M. (2018) · Anesthesia Essays and Researches · doi:10.4103/aer.aer_113_18 · Cited by 8
Perioperative Schmerztherapie mit Nichtopioidanalgetika
Stamer, U. M., Erlenwein, J., Freys, S. M., Stammschulte, T., Stichtenoth, D. O., & Wirz, S. (2021) · Der Chirurg · doi:10.1007/s00104-021-01421-w · Cited by 8
Bolay, H., & Durham, P. L. (2010) · Handbook of clinical neurology · doi:10.1016/s0072-9752(10)97004-8 · Cited by 10
A Review on different types of the Non Steroidal Anti-Inflammatory Drugs (NSAIDs)
(2016) · International Journal of Advanced Multidisciplinary Research · doi:10.22192/ijamr.2016.03.09.007 · Cited by 8
James, L. P. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-387817-5.00020-0 · Cited by 8
Acetaminophen induces mitochondrial apoptosis through proteasome dysfunctions
Jagtap, Y. A., Kumar, P., Dubey, A. R., Kinger, S., Choudhary, A., Karmakar, S., Lal, G., Kumar, A., Kumar, A., Prasad, A., et al. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122732 · Cited by 8
Gelotte, C. K., Vakil, A. M., Zimmerman, B. A., Zannikos, P., Mishra, R., Eichenbaum, G. M., Kuffner, E. K., & Flores, C. M. (2023) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2023.105480 · Cited by 7
Bonnesen, K., Pedersen, L. H., Ehrenstein, V., Grønkjær, M. S., Sørensen, H. T., Hallas, J., Lash, T. L., & Schmidt, M. (2023) · Drug Safety · doi:10.1007/s40264-023-01298-0 · Cited by 8
“NSAIDs are believed to increase cardiovascular risk through several mechanisms including increased atherogenesis in early stages of atherosclerosis [45] and increased systolic blood pressure [46].”
MethodInfluentialGlasser, S. P., & Khodneva, Y. A. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.05035 · Cited by 8
Non-prescription (OTC) oral analgesics for acute pain- an overview of Cochrane reviews
Moore, R. A., Wiffen, P. J., Derry, S., Roy, Y. M., Tyrrell, L., & Derry, C. J. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010794 · Cited by 7
Katsanopoulou, M., Zannas, Z., Ofrydopoulou, A., Maria, C., Krokidis, X., Lambropoulou, D. A., & Τσούπρας, Α. (2025) · Medicina · doi:10.3390/medicina61081413 · Cited by 8
“Since significant inhibition of platelet aggregation typically requires greater than 95% COX-1 inhibition, paracetamol does not substantially impair platelet function, supporting its favorable safety profile compared to traditional NSAIDs [146].”
Part I. Mechanisms of actions and metabolism of acetaminophen related to the neonatal brain
Angelis, D., Savani, R. C., Jagarapu, J., Hu, J., Wan-Huen, P., & Chalak, L. F. (2021) · Early Human Development · doi:10.1016/j.earlhumdev.2021.105406 · Cited by 6
Nonsteroidal Anti-Inflammatory Drugs in Viral Infections Disease, Specially COVID-19
Chamkouri, N., Absalan, F., Koolivand, Z., & Yousefi, M. (2023) · Advanced Biomedical Research · doi:10.4103/abr.abr_148_21 · Cited by 6
“Paracetamol treats pain mainly by blocking COX‐2 and inhibiting endocannabinoid reuptake almost exclusively within the brain, but not much in the rest of the body.[12,13]”
BackgroundRoberts, B. M., Geddis, A. V., Ciuciu, A., Reynoso, M., Mehta, N. K., Varanoske, A. N., Kelley, A. M., Walker, R., Munoz, R., Kolb, A. L., et al. (2024) · The FASEB Journal · doi:10.1096/fj.202302642r · Cited by 6
“8,9 ACE also affects central sites of action that differ from NSAIDs.”
BackgroundPerioperative Schmerztherapie mit Nichtopioidanalgetika
Stamer, U., Erlenwein, J., Freys, S., Stammschulte, T., Stichtenoth, D., & Wirz, S. (2021) · Der Schmerz · doi:10.1007/s00482-021-00566-1 · Cited by 6
Elnaghy, A. M., Elshazli, A. H., badr, A. E.-S., & Elsaka, S. E. (2022) · Australian Endodontic Journal · doi:10.1111/aej.12642 · Cited by 6
Kashif, S., & Hamid, M. (2016) · Journal of Anaesthesiology Clinical Pharmacology · doi:10.4103/0970-9185.173332 · Cited by 6
“The peak analgesic effect is obtained in 1 h and the duration of action is 4-6 h.[5,6] The purpose of the study was to observe the efficacy of intravenous paracetamol in preventing hemodynamic changes due to pain in cesarean sections at intubation, as well as its effect on neonatal Apgar score.”
BackgroundSchmerztherapie bei Kindern und Jugendlichen mit Hämophilie
Stromer, W., Messerer, B., Crevenna, R., Hemberger, S. H., Jauk, B., Schwarz, R., Streif, W., Thom, K., Wagner, B. R., Zwiauer, K., et al. (2018) · Der Schmerz · doi:10.1007/s00482-018-0321-7 · Cited by 6
Transplacental transfer of acetaminophen in pregnant rats
Chen, J.-H., Lin, I.-H., Sun, C., Yang, L., Hsueh, T. Y., Ting, C., & Tsai, T. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113613 · Cited by 6
Acetaminophen versus Ibuprofen in Mild Persistent Asthma.
Sheehan, W. J., & Phipatanakul, W. (2016) · PubMed · doi:10.1056/nejmc1612164 · Cited by 4
Chu, T., Liu, Z., Liu, H., Mu, W., Zhi, Y., Sheng, N., Zhang, J., Peng, X., Lv, S., Duan, K., et al. (2026) · Nature Communications · doi:10.1038/s41467-025-68267-2 · Cited by 8
Metadata
- Authors
- Hinz, B., Cheremina, O., & Brune, K.
- Affiliations
- University of Rostock (DE)
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- ORCID
- Hinz, Burkhard
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2007-09-20
- Volume
- 22
- Issue
- 2
- Pages
- 383-390
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2132889863
- Cited by
- 478
- References
- 51
- Citations by year
- 2026: 13 · 2025: 14 · 2024: 15 · 2023: 14 · 2022: 19 · 2021: 19 · 2020: 14 · 2019: 28 · 2018: 33 · 2017: 29 · 2016: 35 · 2015: 49 · 2014: 28 · 2013: 33 · 2012: 36
- FWCI
- 15.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Keywords
- paracetamol, COX-2 inhibition, COX-1 inhibition, COX-2 inhibitors, thromboxane B2, prostaglandin E2, plasma pharmacokinetics, gastrointestinal safety, cardiovascular risk, analgesic mechanism, anti-inflammatory mechanism
- MeSH terms
- Acetaminophen, Cells, Cultured, Humans, Isoenzymes, Monocytes, Time Factors, Cyclooxygenase 1, Cyclooxygenase 2, Cyclooxygenase 2 Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.